Cite
MLA Citation
Amber Shatzer et al.. “Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.” Leukemia & lymphoma, vol. 58, no. 4, 2017, pp. 923–931. http://access.bl.uk/ark:/81055/vdc_100040164843.0x00002b